Literature DB >> 29855200

Common gene variants interactions related to uric acid transport are associated with knee osteoarthritis susceptibility.

Javier Fernández-Torres1, Gabriela Angélica Martínez-Nava1, Francesca Oliviero2, Alberto Gabriel López-Reyes1, Karina Martínez-Flores1, Daniela Garrido-Rodríguez3, Adriana Francisco-Balderas4, Yessica Zamudio-Cuevas1.   

Abstract

BACKGROUND: The presence of genetic variants in uric acid (UA) transporters can be associated with hyperuricemia, and therefore with an increased risk of monosodium urate (MSU) crystal precipitation. The inflammatory process triggered by these crystals leads to cartilage damage, which, in turn, could promote knee osteoarthritis (KOA).
OBJECTIVE: To determine whether genetic polymorphisms of the UA transporters and their interactions are associated with KOA.
MATERIALS AND METHODS: Two hundred forty-three unrelated Mexican-mestizo individuals were recruited for this case-control study. Ninety-three of them were KOA patients but without gout, and one hundred and fifty healthy individuals with no symptoms or signs of KOA were recruited as controls. Forty-one single-nucleotide polymorphisms (SNPs) involved in the UA transporters were genotyped with OpenArray technology in a QuantStudio 12K flex-System with both cases and controls.
RESULTS: After adjusting by age, gender, BMI, and ancestry, significant associations were found for eight SNPs: rs1260326 (GCKR), rs780093 (GCKR), rs17050272 (INHBB), rs1471633 (PDZK1), rs12129861 (PDZK1), rs7193778 (IGF1R), rs17786744 (STC1), and rs1106766 (R3HDM2). With respect to gene-gene interactions, the pairwise interactions of rs112129861 (PDZK1) and rs7193778 (IGF1R); rs17050272 (INHBB) and rs1106766 (R3HDM2); rs1106766 (R3HDM2) and rs780093 (GCKR); rs1260326 (GCKR) and rs17786744 (STC1); and rs17786744 (STC1) and rs1106766 (R3HDM2) make it possible to visualize the synergistic or antagonistic effect of their genotypes or alleles on KOA development.
CONCLUSIONS: Our preliminary results show that the common gene variants related to UA transport are associated with KOA in the Mexican population. Further studies must be carried out to corroborate it.

Entities:  

Keywords:  Case-control study; gene polymorphism; interactions; knee osteoarthritis; uric acid transporters

Mesh:

Substances:

Year:  2018        PMID: 29855200     DOI: 10.1080/03008207.2018.1483359

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  5 in total

Review 1.  Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Cell Dev Biol       Date:  2022-06-23

2.  Multifactor dimensionality reduction reveals a strong gene-gene interaction between STC1 and COL11A1 genes as a possible risk factor of knee osteoarthritis.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Karina Martínez-Flores; Fernando Mijares-Díaz
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

3.  Role of SREBP2 gene polymorphism on knee osteoarthritis in the South Indian Hyderabad Population: A hospital based study with G595C variant.

Authors:  Subhadra Poornima; Krishna Subramanyam; Imran Ali Khan; Sumanlatha G; Qurratulain Hasan
Journal:  J Orthop       Date:  2019-05-07

4.  Low-Input RNA-Sequencing in Patients with Cartilage Lesions, Osteoarthritis, and Healthy Cartilage.

Authors:  Katherine Wang; Q Y Esbensen; T A Karlsen; C N Eftang; C Owesen; A Aroen; R B Jakobsen
Journal:  Cartilage       Date:  2021-11-15       Impact factor: 4.634

5.  Epistasis of polymorphisms related to the articular cartilage extracellular matrix in knee osteoarthritis: Analysis-based multifactor dimensionality reduction.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Carlos Lozada; Daniela Garrido-Rodríguez; Karina Martínez-Flores
Journal:  Genet Mol Biol       Date:  2020-03-27       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.